Why Eli Lilly Stock Is Bolting Higher Today
Shares of the Illinois-based drugmaker Eli Lilly (NYSE: LLY) were up by 6% on heavy volume as of 1:45 p.m. ET Wednesday.
What sparked this latest rally? Ahead of the opening bell, Lilly announced that its early-stage Alzheimer's disease treatment, donanemab, slowed cognitive decline by a clinically meaningful 35% in a late-stage trial.
By contrast, and Eisai's Food and Drug Administration (FDA)-approved Leqembi, slowed cognitive decline by 27% in a similar patient group, compared to placebo. That being said, there are key differences in the trials between these two drugs, making head-to-head comparisons impossible at this early juncture.
Source Fool.com
Biogen Inc. Stock
With 51 Buy predictions and 2 Sell predictions Biogen Inc. is one of the favorites of our community.
As a result the target price of 283 € shows a very positive potential of 56.27% compared to the current price of 181.1 € for Biogen Inc..